IRONWOOD PHARMACEUTICALS INC ·
IRWD 8-K 2026-10-16
IRONWOOD PHARMACEUTICALS INC (IRWD) 8-K dated 2026-10-16 — accession 0001104659-26-116423. This URL is the filing, not the IRWD hub.
IRONWOOD PHARMACEUTICALS INC (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.
IRONWOOD PHARMACEUTICALS INC filed a 8-K on 2026-10-16. Accession 0001104659-26-116423.
Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported IRWD revenue for 2026-06-30 was $113.0M. Net income was $51.3M. Revenue was up 6.1% from 2026-03-31 to 2026-06-30. IRWD currently screens at market cap $579.4M.
Not investment advice. The IRWD SEC hub lists recent forms. The stock page is the research view.